The effect of written information provided by pharmacists on compliance with antibiotherapy;La información escrita del farmacéutico mejora el cumplimiento de la antibioterapia

Ars Pharmaceutica

Volumn 44, Issue 2, 2003, Pages 141-157

  Machuca, M ^a   Espejo, J ^b   Gutierrez L ^c   Machuca, M P ^c   Herrera, J ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c Farmacéutica Comunitaria en Sevilla ^*  (Spain)

Author keywords

Antibiotherapy; Contradict appropriate antibiotic administration policies; Pharmaceutical care; Therapeutic compliance

Indexed keywords

ANTIBIOTIC AGENT; CLAVULANIC ACID; EXPECTORANT AGENT; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFANILAMIDE; URINARY TRACT ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFECTION; INFORMED CONSENT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHARMACY; PRESCRIPTION; RESPIRATORY TRACT INFECTION; TOOTH INFECTION; TREATMENT REFUSAL; URINARY TRACT INFECTION;

EID: 9944249359     PISSN: 00042927     EISSN: 00042927     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Haynes RB, Taylor DW, Sackett DL. Compliance in health care. The John Hopkins University Press: Baltimore, MD; 1979.
2. Feldman JA, DeTullio PL. Medication noncompliance: an issue to consider in the drug selection process. Hosp Formul 1994; 29: 204-211.
3. Ramalle- Gomara E, Bermejo- Ascorbe R, Alonso Marín R, Marino Alejo I, Sáenz de Cabezón Bustunduy MI, VILLARO Amilburu c. Cumplimiento del tratamiento antibiótico en niños no hospitalizados. Aten Primaria 1999;24: 364-367.
4. Gérvas J. La resistencia a los antibióticos, un problema de Salud Pública. Economía y Salud 1999; 35: 1-7.
5. Grupo URANO. Cumplimiento e incumplimiento terapéutico en el tratamiento antibiótico. Madrid: Doyma; 1997.
6. Sociedad Española de Quimioterapia. Estudio sobre el uso de los antibióticos en España. Madrid: Pfizer; 1994.
7. Abrahams J. Patient compliance in general practice. Australian Family Physician 1977; 6: 1200-1205.
8. Álvarez de Toledo F, Arcos González P, Cabiedes Miragaya L. La nueva Atención Farmacéutica: ¿puede la intervención farmacéutica mejorar la eficiencia terapéutica?. Rev Esp Salud Pública 1995; 69: 277-282.
9. Piscitelli Sc, Occhipinti DJ, Danzinger LH, Hill C, West DP, Fischer JH. Therapeutic monitoring and pharmacist intervention in a Hansen's disease clinic. Ann Pharmacother 1993; 27: 1526-1531.
10. Van Berge Henegouwen MTH, van Driel HF, Kasteleijn- Nost Trenité DGA. A patient diary as a tool to improve medicine compliance. Pharm World Sci 1999; 21 (1): 21-24.
11. Salar L, Dualde E, Bernardeau E, García Cebrián F. Programa TOD (Tratamiento de Observación Directa) de Valencia. Implantación y experiencia iniciales. Pharm Care Esp 2000; 2: 28-41.
12. Consejo Geeral de Colegios Oficiales de Farmacéuticos. Catálogo de Especialidades Farmacéuticas 1998. Madrid: CGCOF; 1998.
13. Cockburn J, Gibberd RW, Reid AL, Sansón- Fisher RW. Determinants of non- compliance with short- term antibiotic regimens. BMJ 1987; 295: 814-818.
14. Zinder DE, Castro KG. The global treta of drug- resistant tuberculosis. N Engl Med 1998; 338 (23): 1689-1690.
15. Bergman U, Wiholm E. Patient medication on admisión to a Medical Clinic. Eur J Clin Pharmacol 1981;20: 185-191.
16. Haynes RB, McKibbon KA, Kanani R, Brouwers MC, Oliver T. Interventions for helping patients to follow prescriptions for medications (Cochrane Review . In: The Cochrane Library, Issue 1, 1999. Oxford: Update Software.
17. Martínez Ibáñez MT, Hernández González E, Méndez García CD, Gómez Juárez JL, Salas Hospital JC, Vázquez Velosos C, Solsona Gimeno R. Comparación de los métodos de encuesta: teléfono frente a correo en la población diabética de un centro de salud. Aten Primaria 1999;23: 198-203.
18. Sociedad Española de Quimioterapia. Estudio sobre el uso de los antibióticos en España. Madrid: Pfizer; 1994.
19. Morris LA, Halpering JA. Effects of written drug information on patient knowledge and compliance: a literature review. Am J Pharm 1979;69 (1): 47-52.
20. Cabezas A, Martín E, Comín J, Sabría C, Boix A, Espínola E et al. Cumplimiento terapéutico en Atención Primaria de Salud. Valor de la receta personalizada. Rev Clin Esp 1989; 185: 360-363.
21. Beardon PHG, McGilchrist MM, McKendrik Ad, McDevitt DG, MacDonald TM. Primary Non- compliance with prescribed medication in primary care. BMJ 1993;307: 846-848.
22. Rashid a. Do patients cash prescriptions ?. BMJ 1982; 284: 24-26.
23. Taquín PA, Stringer RS, Duffy JB, Elion C, Ferraris CS, Misrachi SR, Shenfield GM. The influence of information provided by patients on the accuracy of medication records. Med J Aust 1998; 169 (2): 85-88.
24. Matsumoto K, Nishikawa M, Hashimoto H, Hayakawa H, Chida K, Toyoshima M, Satoh A. Effect of pharmacist's instruction on treatment of ashmatics with inhaled steroid. Aerugi 1998; 47 (4): 404-412.
25. Michael KA, Henderson PL, Newman RB, Blackwelder EN, Caldwell RD. Impact of a pharmacist/ physician cooperative target drug monitoring program on prophylactic antibiotic prescribing in Obstetrics and Gynecology. Hosp Pharm 1992; 27: 213-216.
26. Al- Shammari SA, Khoja T, Al- Yamani MJMS. Compliance with short- term antibiotic therapy among patients attending primary health centres in Riyadh, Saudi Arabia. J Roy Soc Health 1995; (4): 231-234.
27. Reiter Consulting y Gestión. Cumplimiento del tratamiento. Claves económicas de un problema sanitario. Estudio preliminar. Madrid; 1995.
28. Urquhart J. Patient non- compliance with drug regimens : measurement, clinical correlates, economic impact. Eur Heart J 1996 ; 17 (Suppl A) : 8-15.
29. Pullar T, Birtwell AJ, Wiles PG, Hay A, Feely MP. Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clin Pharmacol Ther 1988; 44: 540-545.
30. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frecuency on patient medication compliance. Arch Intern Med 1990; 150: 1881-1884.
31. Roe CM, Motheral BR, Teitelbaum F, Rich MW. Angiotensin- Converting Enzyme Inhibitor compliance and dosimg among patients with heart failure. Am Heart J 1999; 138 (5): 818-825.
32. Garret SS. Deciding between once- and twice- daily dosing. Am J Health- Syst Pharm 1996; 53: 730-731.
33. Cramer JA. Relationship between medication compliance and medical outcomes. Am J Health- Syst Pharm 1995; 52 (Suppl 3): S27-29.
34. Prados Castillejo JA. Importancia de la relación médico- enfermo y la entrevista clínica en el cumplimiento del tratamiento. Inf Ter Sist Nac Salud 1992; 16: 209-216.
35. Lewis RK, Lasack NL, Lambert BL, Connor SE. Patient counselig- a focus on maintenace therapy. Am J Health- Syst Pharm 1997; 54: 2084-2098.